Is Sickle Cell Disease Dominant or Recessive?

Sickle cell disease is an autosomal recessive genetic condition: a person usually needs to inherit an altered hemoglobin gene from both parents to have the disease. Having one altered gene is called sickle cell trait and is often harmless, although it can still be passed to children.

The short answer: sickle cell disease is recessive

Sickle cell disease is autosomal recessive. This means that a person generally develops the disease when they inherit two altered copies of the hemoglobin beta (HBB) gene—one from each parent. The gene is located on a non-sex chromosome, so the inheritance pattern is the same for people of all sexes.

In contrast, a person who inherits one altered HBB gene and one usual copy has sickle cell trait. Most people with the trait are healthy and do not develop the ongoing anemia, pain episodes, or organ complications associated with sickle cell disease. Learning about trait status is nevertheless useful for family planning and for interpreting certain blood test results.

Having a family history of sickle cell trait or disease does not mean that a person is unwell. Many people only discover they carry the trait through newborn screening, routine testing, or testing before having children. A clinician can explain what an individual or couple’s results mean.

What the genes mean for parents and children

Genes are inherited in pairs. In the most common form of sickle cell disease, the altered gene leads to production of hemoglobin S, a form of hemoglobin that can change the shape of red blood cells under certain conditions. A person with two hemoglobin S genes has sickle cell anemia, often written as HbSS.

If both parents have sickle cell trait, each pregnancy has the same possible outcomes: a 25% chance that the child will inherit two altered genes and have sickle cell disease, a 50% chance that the child will inherit one altered gene and have sickle cell trait, and a 25% chance that the child will inherit no altered gene. These probabilities apply separately to every pregnancy and do not predict the outcome of a particular pregnancy.

If one parent has sickle cell trait and the other does not carry a relevant hemoglobin gene variant, their children cannot inherit typical sickle cell disease from that pairing, although some may inherit the trait. A parent with sickle cell disease can also pass an altered gene to every biological child. The other parent’s test result determines whether a child could have sickle cell disease.

Other inherited hemoglobin variants can combine with hemoglobin S and cause forms of sickle cell disease, such as hemoglobin SC disease or sickle beta-thalassemia. This is why comprehensive testing and genetic counseling can be especially helpful when a family has known hemoglobin conditions.

Sickle cell trait versus sickle cell disease

Sickle cell trait and sickle cell disease are not the same. Sickle cell disease is a group of lifelong inherited blood disorders in which red blood cells may become rigid and sickle-shaped. They can break down sooner than usual and may obstruct small blood vessels, reducing oxygen delivery to tissues.

People with sickle cell disease may experience anemia, tiredness, yellowing of the skin or eyes, repeated infections, swelling of the hands and feet in early childhood, and episodes of significant pain. Symptoms and severity vary widely between individuals and between different forms of the condition. For a broader explanation of the condition, see sickle cell disease.

People with sickle cell trait usually have no symptoms and live typical lives. Rare health problems have been reported in extreme circumstances, including severe dehydration, very high altitude, low oxygen environments, or unusually intense physical exertion. Those with the trait should inform clinicians of their status and seek individualized advice before high-altitude travel, diving, or demanding athletic or military training.

Trait status is not contagious and cannot be acquired later in life. It is inherited at conception, although a person may not know their status until testing is performed.

How doctors diagnose sickle cell conditions

Doctors diagnose sickle cell disease and sickle cell trait with blood testing. Many countries include screening for sickle cell conditions in newborn screening programs. Early identification allows children with sickle cell disease to receive preventive care and monitoring before complications occur.

A blood test called hemoglobin electrophoresis, high-performance liquid chromatography, or another hemoglobin analysis can identify the types of hemoglobin present. A complete blood count may assess anemia and red blood cell characteristics. Genetic testing may be used when results are unclear, when a rare variant is suspected, or for family planning.

When a person is found to have sickle cell trait, clinicians may recommend testing the reproductive partner before pregnancy or early in pregnancy. Genetic counseling can provide clear, non-directive information about inheritance, testing choices, and possible reproductive options. This support can help families make decisions that fit their circumstances and values.

A doctor also considers whether anemia or symptoms could have another cause. Iron deficiency, thalassemia, infection, and other blood conditions can affect blood counts, so test findings should be interpreted in the context of a person’s health and family history.

Treatment and everyday care for sickle cell disease

There is no single treatment plan that suits every person with sickle cell disease. Care aims to prevent complications, manage symptoms promptly, support healthy development, and protect long-term organ health. A hematology team may recommend vaccinations, infection prevention measures, regular blood monitoring, and medicines that reduce pain episodes or other complications when appropriate.

During a pain episode, treatment may include fluids, pain relief, warmth, rest, and assessment for triggers or complications. Some episodes can be managed at home using a clinician-approved plan, while others require hospital care. Blood transfusions may be needed in selected situations, such as severe anemia, stroke prevention, or certain acute complications.

For some people, a stem cell transplant may be considered as a potential curative approach, depending on disease severity, donor availability, age, overall health, and individual treatment goals. It involves important benefits and risks that require detailed discussion with an experienced specialist. Bone marrow transplantation is one option that may be evaluated by a specialized team.

Everyday measures such as drinking adequate fluids, avoiding extreme temperatures where possible, keeping vaccinations up to date, taking prescribed medicines, and attending scheduled reviews can support health. People should not start supplements or change prescribed treatment without advice from their care team.

When to seek medical care

People with sickle cell trait who feel well usually do not need urgent care because of their carrier status alone. They should arrange a routine medical discussion if they have not had confirmatory testing, are planning a pregnancy, have a partner with a known hemoglobin condition, or need advice about strenuous activity or high-altitude exposure.

Someone known or suspected to have sickle cell disease should seek urgent medical assessment for fever, chest pain, shortness of breath, new severe headache, weakness or numbness on one side, confusion, fainting, seizures, a painful erection lasting more than four hours, or sudden worsening pain. These symptoms may indicate complications that benefit from prompt treatment.

Medical review is also important for increasing fatigue, pale skin, jaundice, persistent abdominal swelling, reduced urine output, or pain that is not improving with the person’s agreed care plan. In infants and young children, fever, unusual sleepiness, breathing difficulty, poor feeding, or marked irritability should be assessed without delay.

Acıbadem Health Point’s multidisciplinary specialists and JCI-accredited hospitals can assess and treat sickle cell disease for international patients, including support with diagnosis, hematology care, and treatment planning.

Prevention, screening, and family planning

Sickle cell disease cannot be prevented after a child inherits two altered hemoglobin genes, but screening can identify affected newborns early and help prospective parents understand their chances of passing on a hemoglobin condition. Testing is particularly relevant for people with a personal or family history of sickle cell disease, sickle cell trait, thalassemia, or unexplained anemia.

Preconception or prenatal counseling can explain available testing approaches. Depending on local practice and personal circumstances, options may include carrier testing before pregnancy, testing during pregnancy, or assisted reproductive approaches with genetic testing. These are personal decisions, and a genetic counselor or specialist can discuss them without pressure.

For individuals living with sickle cell disease, prevention also includes regular follow-up and prompt care for infections and other symptoms. A personalized plan is especially important before pregnancy, surgery, long-distance travel, or activities likely to involve dehydration or reduced oxygen exposure.

Clear communication within families can be valuable. Relatives may choose testing because carrier status can be passed through generations without causing obvious symptoms in people who have sickle cell trait.

Frequently asked questions